You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 July 2015
Veloxis Announces U.S. FDA Approval of Envarsus® XR for Treatment of Kidney Transplant Patients
24 June 2015
Envarsus® XR Demonstrates Differentiated Pharmacokinetic Profile Compared to Twice-Daily Prograf® or Once-Daily Astagraf XL® in Stable Kidney Transplant Patients
12 June 2015
U.S. District Court Rules in Veloxis Litigation
3 June 2015
Warrant Programme – Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants
4 May 2015
Envarsus® XR Demonstrates Improved Pharmacokinetic Profile in African-American Transplant Recipients
27 March 2015
Veloxis Pharmaceuticals A/S establishes new Warrant Programme